# Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors

> **NCT07161310** · NA · RECRUITING · sponsor: **Goethe University** · enrollment: 45 (estimated)

## Conditions studied

- Solid Cancer
- Non-Small Cell Lung Cancer
- Melanoma

## Interventions

- **DIETARY_SUPPLEMENT:** Urolithin A
- **DIETARY_SUPPLEMENT:** Placebo
- **OTHER:** Bio specimens

## Key facts

- **NCT ID:** NCT07161310
- **Lead sponsor:** Goethe University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-02
- **Primary completion:** 2027-01
- **Final completion:** 2027-03
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07161310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07161310, "Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07161310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*